Viewing StudyNCT05445011



Ignite Creation Date: 2024-05-06 @ 5:50 PM
Last Modification Date: 2024-10-26 @ 2:36 PM
Study NCT ID: NCT05445011
Status: RECRUITING
Last Update Posted: 2022-07-06
First Post: 2022-06-23

Brief Title: Anti-FLT3 CAR-T Cell TAA05 Cell Injection in the Treatment of Relapsed Refractory Acute Myeloid Leukemia
Sponsor: Wuhan Union Hospital China
Organization: Wuhan Union Hospital China

Organization Data

Organization: Wuhan Union Hospital China
Class: OTHER
Study ID: Anti-FLT3 CAR-T Cell
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Wuhan Union Hospital China
Lead Sponsor Class: OTHER
Responsible Party: MEI HENG
Responsible Party Title: Proferssor Cheif Doctor
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Wuhan Union Hospital China
Old Name: None
Old Organization: None

Collaborators

Name Class
PersonGen BioTherapeutics Suzhou Co Ltd INDUSTRY